Exploring the Therapeutic Efficacy of Medicinal Plants Against Hypertension and Skin Depigmentation

Hypertension and skin depigmentation disorders are increasingly prevalent chronic conditions affecting global public health. Hypertension is a major risk factor for cardiovascular diseases, stroke, renal failure, and premature mortality, whereas depigmentary disorders such as vitiligo significantly impair psychological and social well-being. Conventional therapies for these disorders often produce adverse effects, limited efficacy, and high treatment costs, leading to growing interest in alternative therapeutic approaches. Medicinal plants have emerged as promising sources of bioactive compounds with antihypertensive, antioxidant, anti-inflammatory, immunomodulatory, and melanogenic activities. The present study explores the therapeutic efficacy of medicinal plants in the management of hypertension and skin depigmentation disorders. Medicinal plants such as Allium sativum (garlic), Hibiscus sabdariffa, Rauwolfia serpentina, Camellia sinensis (green tea), Psoralea corylifolia, Curcuma longa (turmeric), Azadirachta indica (neem), and Aloe vera contain phytochemicals including flavonoids, alkaloids, terpenoids, polyphenols, and psoralens that exert pharmacological effects through multiple biological pathways. These plants act by promoting vasodilation, inhibiting angiotensin-converting enzyme activity, reducing oxidative stress, suppressing inflammatory mediators, and stimulating melanocyte proliferation and melanin synthesis. Recent pharmacological and clinical studies support the effectiveness of herbal therapies in reducing blood pressure and improving skin repigmentation. However, lack of standardization, limited clinical trials, and safety concerns remain major challenges in the integration of herbal medicines into conventional healthcare systems. This study highlights the therapeutic significance of medicinal plants and emphasizes the need for further scientific investigations and evidence-based validation.